Scienture Holdings CEO and President resign; Nasdaq bid-price deficiency received

Scienture Holdings, Inc.

CEO Suren Ajjarapu and Chairman resigned May 16; President Prashant Patel resigned May 20, both no disputes.
Dr. Narasimhan Mani and Dr. Shankar Hariharan appointed co-CEOs effective May 20; Mani also President and director.
Terminated purchase agreement with Arena Business Solutions Global SPC II effective May 22, no penalties.
Nasdaq notice May 19: bid price below $1 for 30 days; 180 days until Nov 17, 2025 to regain compliance.

item 1.02item 1.01item 3.01item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Suren Ajjarapu

Chief Executive Officer and Chairman of the Board

SCNX · Scienture Holdings, Inc.

Effective: 2025-05-16
Successor: Dr. Narasimhan Mani, Dr. Shankar Hariharan
Filed: May 22, 2025 23:59 UTC

On May 16, 2025, as part of a planned leadership succession, Suren Ajjarapu advised the Company that he was resigning from his position as the Company’s Chief Executive Officer and Chairman of the Board effective immediately.

Appointed

Dr. Narasimhan Mani

co-Chief Executive Officer, President and Director

SCNX · Scienture Holdings, Inc.

Effective: 2025-05-20
Filed: May 22, 2025 23:59 UTC

the Company’s board of directors appointed Dr. Narasimhan Mani, age 50, and Dr. Shankar Hariharan, age 68, to serve as co-Chief Executive Officers of the Company effective as of May 20, 2025.

Departed

Prashant Patel

President and Chief Operating Officer

SCNX · Scienture Holdings, Inc.

Effective: 2025-05-20
Successor: Dr. Narasimhan Mani
Filed: May 22, 2025 23:59 UTC

As part of the planned leadership transition, Prashant Patel also advised the Company that he was resigning from his position as the Company’s President and Chief Operating Officer, effective as of May 20, 2025.

Appointed

Dr. Shankar Hariharan

Executive Chairman and co-Chief Executive Officer

SCNX · Scienture Holdings, Inc.

Effective: 2025-05-20
Filed: May 22, 2025 23:59 UTC

The board of directors also appointed Dr. Mani to serve as a director on the Company’s board of directors to fill the vacancy created as a result of Mr. Ajjarapu’s resignation and appointed Dr. Hariharan to the position of Executive Chairman of the Company’s board of directors, each effective as of May 20, 2025.

Source: SEC EDGAR

accession 0001641172-25-011945

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.